Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation TCT 2025

Optimizing PCI Outcomes After ACS: Anti-Inflammatory Therapies - unCLEAR SYNERGies?

Presenter: Sanjit S. Jolly

October 27, 2025

Presentation TCT 2025

TCT 774: Anti-inflammatory Nanoparticles for Enhanced Treatment of Peripheral Arterial Disease

Presenter: Richard Tan

October 26, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Presenter: Duk-Woo Park

October 26, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Presenter: Beth Davison

February 12, 2025

Presentation TCT 2024

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

Presenter: Jennifer Rymer

October 29, 2024

Presentation Controversies and Advances 2023

Anti-inflammatory Drugs to Inhibit Atherosclerosis: Old and New

Presenter: Christie M. Ballantyne

November 30, 2023

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

Presenter: Sanjit Jolly

September 19, 2022

Presentation ACC 2018

CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Presenter: Brendan M. Everett

March 12, 2018

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

Presentation TCT 2016

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Presenter: Gregg W. Stone, Ron Waksman, Sanjit S. Jolly

November 01, 2016

Presentation TCT 2016

Anti-inflammatory Therapies for Atherosclerosis

Presenter: Robert A. Harrington, A. Michael Lincoff, Jean-Claude Tardif

October 30, 2016

Presentation

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presenter: Schjerning Olsen

October 28, 2015

Presentation

Vascular and Upper Gastrointestinal Effects of Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Presenter: CNT Collaboration

May 31, 2013

Presentation TCT 2013

Abluminal- Only Coating Everolimus Eluting Coronary Stent Provides an Anti-inflammatory Vascular Effect Compared to Bare Metal Stents in the Familial Hypercholesterolemic Swine

Presenter: Armando Tellez, Elina Donskoy, Natalia Sushkova, Paul Seifert, Taylor Palmieri, William Rate, Samantha Stone, Michael Eppihimer, Greg Kaluza, Barbara Huibregtse, Keith Dawkins, Juan Granada

January 31, 2013

Presentation

Targeted Anti-inflammatory Systemic Therapy for Restenosis: BLAST Study

Presenter: Shmuel Banai

January 10, 2013

Presentation TCT 2012

Anti-inflammatory Effect of Arsenic Trioxide Eluting Stents in a porcine coronary model

Presenter: Li Shen, Wei Yang, Feirong Gong, Yizhe Wu, Juying Qian, Aijun Sun, Yunzeng Zou, Junbo Ge

January 03, 2012

Advertisement

Optimizing PCI Outcomes After ACS: Anti-Inflammatory Therapies - unCLEAR SYNERGies?

TCT 774: Anti-inflammatory Nanoparticles for Enhanced Treatment of Peripheral Arterial Disease

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

Anti-inflammatory Drugs to Inhibit Atherosclerosis: Old and New

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Anti-inflammatory Therapies for Atherosclerosis

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Vascular and Upper Gastrointestinal Effects of Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Abluminal- Only Coating Everolimus Eluting Coronary Stent Provides an Anti-inflammatory Vascular Effect Compared to Bare Metal Stents in the Familial Hypercholesterolemic Swine

Targeted Anti-inflammatory Systemic Therapy for Restenosis: BLAST Study

Anti-inflammatory Effect of Arsenic Trioxide Eluting Stents in a porcine coronary model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content